Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Promising findings announced for plague vaccine

May 13, 2003

Development of CEL-1000 for herpes simplex funded by NIAID

May 12, 2003

DOR BioPharma signs license agreement for botulinum toxin vaccine technology

May 9, 2003

StreptAvax stimulates broad immune response in phase II study

May 8, 2003

Further positive results from FluINsure challenge study

May 7, 2003

Neose and GSK enter into license agreement

May 6, 2003

Search for SARS treatment at Medarex and MBL

April 29, 2003

GenVec and NIAID to develop SARS vaccine

April 29, 2003

Potential new immunosuppressant for use in transplantation isolated from Chinese herbs

April 25, 2003

Chiron acquires rights to aerosolized ciclosporin from Novartis

April 25, 2003

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...